Literature DB >> 27663546

Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.

Ayna Alfadhli1, Andrew Mack1, Logan Harper1, Sam Berk1, Christopher Ritchie1, Eric Barklis2.   

Abstract

We have analyzed a set of quinolinequinones with respect to their reactivities, cytotoxicities, and anti-HIV-1 properties. Most of the quinolinequinones were reactive with glutathione, and several acted as sulfhydryl crosslinking agents. Quinolinequinones inhibited binding of the HIV-1 matrix protein to RNA to varying degrees, and several quinolinequinones showed the capacity to crosslink HIV-1 matrix proteins in vitro, and HIV-1 structural proteins in virus particles. Cytotoxicity assays yielded quinolinequinone CC50 values in the low micromolar range, reducing the potential therapeutic value of these compounds. However, one compound, 6,7-dichloro-5,8-quinolinequinone potently inactivated HIV-1, suggesting that quinolinequinones may prove useful in the preparation of inactivated virus vaccines or for other virucidal purposes.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIV; Quinolinequinone; Virus

Mesh:

Substances:

Year:  2016        PMID: 27663546      PMCID: PMC5065790          DOI: 10.1016/j.bmc.2016.09.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  36 in total

1.  Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives.

Authors:  Yu Cheng; Lin-Kun An; Ning Wu; Xiao-Dong Wang; Xian-Zhang Bu; Zhi-Shu Huang; Lian-Quan Gu
Journal:  Bioorg Med Chem       Date:  2008-02-15       Impact factor: 3.641

2.  Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.

Authors:  Adele Bolognese; Gaetano Correale; Michele Manfra; Anna Esposito; Ettore Novellino; Antonio Lavecchia
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 3.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Synthesis and cytotoxic activity of metallic complexes of lawsone.

Authors:  Sandra Oramas-Royo; Concepción Torrejón; Irene Cuadrado; Rita Hernández-Molina; Sonsoles Hortelano; Ana Estévez-Braun; Beatriz de Las Heras
Journal:  Bioorg Med Chem       Date:  2013-03-14       Impact factor: 3.641

6.  Second-site compensatory mutations of HIV-1 capsid mutations.

Authors:  Colleen M Noviello; Claudia S López; Ben Kukull; Henry McNett; Amelia Still; Jacob Eccles; Rachel Sloan; Eric Barklis
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

7.  Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.

Authors:  Deepak Bhasin; Somsundaram N Chettiar; Jonathan P Etter; May Mok; Pui-Kai Li
Journal:  Bioorg Med Chem       Date:  2013-05-18       Impact factor: 3.641

8.  Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.

Authors:  Ayna Alfadhli; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

9.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

10.  Structural interactions between retroviral Gag proteins examined by cysteine cross-linking.

Authors:  M S Hansen; E Barklis
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more
  3 in total

1.  Highly Active Small Aminated Quinolinequinones against Drug-Resistant Staphylococcus aureus and Candida albicans.

Authors:  Hatice Yıldırım; Nilüfer Bayrak; Mahmut Yıldız; Fatıma Nur Yılmaz; Emel Mataracı-Kara; Deepak Shilkar; Venkatesan Jayaprakash; Amaç Fatih TuYuN
Journal:  Molecules       Date:  2022-05-03       Impact factor: 4.927

Review 2.  5,8-Quinolinedione Scaffold as a Promising Moiety of Bioactive Agents.

Authors:  Monika Kadela-Tomanek; Ewa Bębenek; Elwira Chrobak; Stanisław Boryczka
Journal:  Molecules       Date:  2019-11-14       Impact factor: 4.411

3.  Natural-product-inspired design and synthesis of thiolated coenzyme Q analogs as promising agents against Gram-positive bacterial strains: insights into structure-activity relationship, activity profile, mode of action, and molecular docking.

Authors:  Hatice Yıldırım; Mahmut Yıldız; Nilüfer Bayrak; Emel Mataracı-Kara; Berna Özbek-Çelik; Masami Otsuka; Mikako Fujita; Mohamed O Radwan; Amaç Fatih TuYuN
Journal:  RSC Adv       Date:  2022-07-15       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.